Stephen Friend

63.6k total citations · 12 hit papers
133 papers, 28.4k citations indexed

About

Stephen Friend is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stephen Friend has authored 133 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 41 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Stephen Friend's work include Cancer-related Molecular Pathways (32 papers), Cancer Genomics and Diagnostics (18 papers) and Bioinformatics and Genomic Networks (18 papers). Stephen Friend is often cited by papers focused on Cancer-related Molecular Pathways (32 papers), Cancer Genomics and Diagnostics (18 papers) and Bioinformatics and Genomic Networks (18 papers). Stephen Friend collaborates with scholars based in United States, United Kingdom and Canada. Stephen Friend's co-authors include René Bernards, Hongyue Dai, Peter S. Linsley, Matthew J. Marton, Robert A. Weinberg, Yudong D. He, Mao Mao, Marc J. van de Vijver, George J. Schreiber and Chris Roberts and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Stephen Friend

131 papers receiving 27.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression profiling predicts clinical outcome of breast cancer

2002 7.0k citations Hongyue Dai, Marc J. van de Vijver et al. Nature profile →
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

1990 2.8k citations J Kassel, Stephen Friend et al. profile →
Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates

2012 2.5k citations Gregory Hannum, Justin Guinney et al. Molecular Cell profile →
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

1986 2.2k citations Stephen Friend, René Bernards et al. Nature profile →
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

1988 1.2k citations Peter Whyte, Karen Buchkovich et al. Nature profile →
Genetics of gene expression surveyed in maize, mouse and man

2003 1.1k citations John R. Lamb, Mao Mao et al. Nature profile →
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

1997 760 citations Stephen Friend et al. profile →
Signaling and Circuitry of Multiple MAPK Pathways Revealed by a Matrix of Global Gene Expression Profiles

2000 691 citations Christopher J. Roberts, Matthew J. Marton et al. profile →
Integrating Genetic Approaches into the Discovery of Anticancer Drugs

1997 567 citations Leland H. Hartwell, Christopher J. Roberts et al. profile →
Drug target validation and identification of secondary drug target effects using DNA microarrays

1998 479 citations Matthew J. Marton, Joseph L. DeRisi et al. Nature Medicine profile →
The mPower study, Parkinson disease mobile data collected using ResearchKit

2016 404 citations Brian M. Bot, Christine Suver et al. Scientific Data profile →
Key Issues as Wearable Digital Health Technologies Enter Clinical Care

2024 52 citations Stephen Friend et al. profile →

Peers

Countries citing papers authored by Stephen Friend

Since Specialization

Citations

This map shows the geographic impact of Stephen Friend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Friend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Friend more than expected).

Fields of papers citing papers by Stephen Friend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Friend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Friend. The network helps show where Stephen Friend may publish in the future.

Co-authorship network of co-authors of Stephen Friend

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Friend. A scholar is included among the top collaborators of Stephen Friend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Friend. Stephen Friend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishing the research priorities for major trauma in the United Kingdom: A Delphi study of nurses and allied health professionals 2023 ·International Emergency Nursing ·Heather Jarman, Robert Crouch, Stephen Friend, Elaine Cole	0
2	The Post-Roe Political Landscape Demands a Morality of Caution for Women’s Health 2022 ·Journal of Medical Internet Research ·Sarah Goodday, (unknown), Christine Suver, Stephen Friend	5
3	Detecting the impact of subject characteristics on machine learning-based diagnostic applications 2019 ·npj Digital Medicine ·Elias Chaibub Neto, Abhishek Pratap, Thanneer M. Perumal, (unknown), Phil Snyder, Brian M. Bot, Andrew D. Trister, Stephen Friend, Lara M. Mangravite, Larsson Omberg	46
4	Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes 2017 ·Science Translational Medicine ·A. Axelsson, Emily Tubbs, Brig Mecham, Shaji Chacko, (unknown), Yunzhao Tang, Jed W. Fahey, Jonathan M.J. Derry, Claes B. Wollheim, Nils Wierup, Morey W. Haymond, Stephen Friend, Hindrik Mulder, Anders H. Rosengren	257
5	Challenges in identifying cancer genes by analysis of exome sequencing data 2016 ·Nature Communications ·Matan Hofree, Hannah Carter, Jason F. Kreisberg, Sourav Bandyopadhyay, Paul S. Mischel, Stephen Friend, Trey Ideker	29
6	The mPower study, Parkinson disease mobile data collected using ResearchKit breakdown → 2016 ·Scientific Data ·Brian M. Bot, Christine Suver, Elias Chaibub Neto, Michael Kellen, Arno Klein, J Christopher Bare, Megan Doerr, Abhishek Pratap, John Wilbanks, E. Ray Dorsey, Stephen Friend, Andrew D. Trister	404
7	Colorectal Cancer Subtyping Consortium (CRCSC) Identifies Consensus of Molecular Subtypes 2014 ·Annals of Oncology ·Rodrigo Dienstmann, Justin Guinney, Mauro Delorenzi, Aurélien de Reyniès, Paul Roepman, Anguraj Sadanandam, Louis Vermeulen, Andreas Schlicker, Edoardo Missiaglia, Charlotte Soneson, Laëtitia Marisa, Krisztián Homicskó, (unknown), Iris Simón, Pierre Laurent‐Puig, Lodewyk F.A. Wessels, Jan Paul Medema, Scott Kopetz, Stephen Friend, Sabine Tejpar	4
8	Colorectal Cancer Subtyping Consortium (CRCSC) identification of a consensus of molecular subtypes. 2014 ·Journal of Clinical Oncology ·Rodrigo Dienstmann, Justin Guinney, Mauro Delorenzi, Aurélien de Reyniès, Paul Roepman, Anguraj Sadanandam, Louis Vermeulen, Andreas Schlicker, Edoardo Missiaglia, Charlotte Soneson, Laëtitia Marisa, Krisztián Homicskó, Xin Wang, Iris Simón, Pierre Laurent‐Puig, Lodewyk F.A. Wessels, Jan Paul Medema, Scott Kopetz, Stephen Friend, Sabine Tejpar	39
9	Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology 2013 ·Clinical Cancer Research ·Charles Ferté, Andrew D. Trister, Erich Huang, Brian M. Bot, Justin Guinney, Frédéric Commo, Solveig K. Sieberts, Fabrice André, Benjamin Besse, Jean‐Charles Soria, Stephen Friend	33
10	Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients 2013 ·Clinical Cancer Research ·Justin Guinney, Charles Ferté, Jonathan R. Dry, Robert McEwen, Gilles Manceau, (unknown), Kai‐Ming Chang, Claus Bendtsen, Kevin Hudson, Erich Huang, Brian Dougherty, Michel Ducreux, Jean‐Charles Soria, Stephen Friend, Jonathan M.J. Derry, Pierre Laurent‐Puig	30
11	Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates breakdown → 2012 ·Molecular Cell ·Gregory Hannum, Justin Guinney, Ling Zhao, Li Zhang, Guy Hughes, SriniVas R. Sadda, Brandy Klotzle, Marina Bibikova, Jian-Bing Fan, Yuan Gao, (unknown), (unknown), Indika Rajapakse, Stephen Friend, Trey Ideker, Kang Zhang	2548
12	Developing predictive molecular maps of human disease through community-based modeling 2012 ·Nature Genetics ·Jonathan M.J. Derry, Lara M. Mangravite, Christine Suver, (unknown), David C. Henderson, (unknown), Brian M. Bot, Jonathan G. Izant, Solveig K. Sieberts, Michael Kellen, Stephen Friend	36
13	A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients 2005 ·Cancer Research ·Hongyue Dai, Laura van’t Veer, John R. Lamb, Yudong D. He, Mao Mao, Bernard M. Fine, René Bernards, Marc J. van de Vijver, Paul Deutsch, Alan B. Sachs, Roland Stoughton, Stephen Friend	207
14	Toxicogenomics and drug discovery: will new technologies help us produce better drugs? 2002 ·Nature Reviews Drug Discovery ·Roger G. Ulrich, Stephen Friend	120
15	Widespread aneuploidy revealed by DNA microarray expression profiling 2000 ·Nature Genetics ·Timothy R. Hughes, Chris Roberts, Hongyue Dai, Allan R. Jones, Markus R. Meyer, David Slade, Julja Burchard, Sally Dow, Teresa R. Ward, M. Kidd, Stephen Friend, Matthew J. Marton	384
16	Drug target validation and identification of secondary drug target effects using DNA microarrays breakdown → 1998 ·Nature Medicine ·Matthew J. Marton, Joseph L. DeRisi, (unknown), Vishwanath R. Iyer, Michael R. Meyer, Christopher J. Roberts, Roland Stoughton, Julja Burchard, David Slade, Hongyue Dai, Douglas E. Bassett, Leland H. Hartwell, Patrick O. Brown, Stephen Friend	479
17	Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae 1998 ·Nature Genetics ·Hideki Shimodaira, (unknown), Hiroyuki Shibata, Takao Suzuki, Paolo Radice, Ryunosuke Kanamaru, Stephen Friend, Richard D. Kolodner, Chikashi Ishioka	111
18	Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. 1994 ·Journal of Clinical Oncology ·(unknown), Birgitte Smith‐Sørensen, Stephen Friend, (unknown), (unknown), Yu-Xin Yan, Carolyn Russo, Junko Sato, (unknown), J. Miser	145
19	p53 Functions as a Cell Cycle Control Protein in Osteosarcomas 1990 ·Molecular and Cellular Biology ·Lisa Diller, J Kassel, (unknown), (unknown), (unknown), Mark C. Gebhardt, Brigitte Bressac–de Paillerets, Mehmet Öztürk, Suzanne J. Baker, Bert Vogelstein, Stephen Friend	209
20	Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product breakdown → 1988 ·Nature ·Peter Whyte, Karen Buchkovich, Jonathan M. Horowitz, Stephen Friend, (unknown), Robert A. Weinberg, Ed Harlow	1219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact